Indication
Vemurafenib is indicated in monotherapy for the treatment of adult patients with BRAF-V600-mutation-positive unresectable or metastatic melanoma.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- ZelborafBrazil · Produtos Roche Químicos e Farmacêuticos S.A.Same brand
- ZelborafCanada · 240 MG · Tablet · Hoffmann-LA Roche LimitedSame brand
- ZELBORAF 240 mg COMPRIMIDOS RECUBIERTOS CON PELICULASpain · 240 mg · comprimido recubierto con película · Roche Registration GmbhSame brand
- ZelborafCroatiaSame brand